InvestorsHub Logo
Followers 0
Posts 3509
Boards Moderated 0
Alias Born 05/28/2006

Re: None

Sunday, 06/01/2008 1:07:46 AM

Sunday, June 01, 2008 1:07:46 AM

Post# of 170
Looks like Amgen is working through their phase II of Rh-Apo2L for non small cell lung cancer. Amgen's Rh-Apo2L is called AMG 951.

http://clinicaltrials.gov/ct2/show/NCT00508625

Primary results for Amgen's phase II for NSCLC estimated by February of next year. It will be interesting to see how all of this plays out.

There are a few studies out there for Rh-Apo2L and they all seem promising.